Brian M. King
Plus aucun poste en cours
Profil
Brian M.
King has been Chairman of Draxis Health, Inc. since May 26, 1994.
He is a Director of Onex Corporation and Chairman of the Compensation Committee.
Mr. King is a Director of VenGrowth Investment Funds and a Member of the Investment, Valuation and Audit Committees.
He was Chairman and Chief Executive Officer of Connaught Biosciences, Inc. Mr. King received a Bachelor of Chemical Engineering degree from the University of Adelaide.
Anciens postes connus de Brian M. King
| Sociétés | Poste | Fin |
|---|---|---|
| ONEX CORPORATION | Directeur/Membre du Conseil | 21/05/2009 |
| Connaught Biosciences, Inc. | Président | - |
Deprenyl Research Ltd.
 Deprenyl Research Ltd. Pharmaceuticals: MajorHealth Technology Deprenyl Research Ltd. manufactures, develops, produces and distributes diagnostic and therapeutic products. The company was headquartered in Kirkland, Canada. | Président | - |
Formation de Brian M. King
| University of Adelaide | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ONEX CORPORATION | Finance |
| Entreprise privées | 2 |
|---|---|
Deprenyl Research Ltd.
Deprenyl Research Ltd. Pharmaceuticals: MajorHealth Technology Deprenyl Research Ltd. manufactures, develops, produces and distributes diagnostic and therapeutic products. The company was headquartered in Kirkland, Canada. | Health Technology |
| Connaught Biosciences, Inc. | Commercial Services |
